证券之星消息，根据天眼查APP信息整理，7月17日公布的《开封市中心医院新院区信息化建设升级改 造项目（二次）-结果公告》中显示东软集团股份有限公司中标。公告内容如下： 开封市中心医院新院区信息化建设升级改造项目（二次）第二包段结果公告河南蓝飞驰工程管理有限公 司受开封市中心医院的委托，就开封市中心医院新院区信息化建设升级改造项目第二包段进行公开招 标，于2025年7月10日在开封市公共资源交易中心定标室通过核查随机法进行定标。现将本次中标结果 公示如下： 一、招标项目说明 1.1、项目名称： 开封市中心医院新院区信息化建设升级改造项目 1.2、项目编号：HNLFC-2025-0315 1.3、招标方式：公开招标 1.4、预算金额：1416.5*****万元；其中：第一包段：40*****.00元，第二包段：101*****.55元 1.5、资金来源：政府专项债劵及单位筹措 二、标段划分情况 2.1、招标范围：拟建设集成平台、数据中心、无纸化归档，病历内涵质控平台、冶疗管理系统等，以 及部分系统升级改造及招标文件的所有内容； 2.2、交货期：合同签订后210日历天内供货、安装、调式完毕 2.3、质保期：自验收 ...

证券代码：600718 证券简称：东软集团 公告编号：临 2025-051 东软集团股份有限公司 关于获得政府补助的公告 特此公告。 东软集团股份有限公司董事会 二〇二五年七月十五日 一、获得补助的基本情况 本公司于 2025 年 7 月 14 日收到 1,320 万元与收益相关的政府补助，占公司 2024 年度经审计归属于母公司股东的净利润 20.94%。 二、补助类型及其对上市公司的影响 根据《企业会计准则第 16 号—政府补助》等相关规定，本次政府补助属于 与收益相关的政府补助，将对公司 2025 年度的利润产生积极影响，具体的会计 处理以会计师事务所审计确认后的结果为准，敬请广大投资者注意投资风险。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 ...

Core Points - The company has approved the cancellation of 18,225,976 repurchased shares, which will reduce the total share capital to 1,189,203,552 shares after the cancellation on July 10, 2025 [1][3] - The repurchase was conducted at a minimum price of 6.41 RMB per share and an average price of 7.96 RMB per share, with a total expenditure of approximately 145 million RMB [2] - The company has completed the necessary procedures for notifying creditors regarding the share cancellation, and no creditors have requested early debt repayment or guarantees [2][3] Repurchase Implementation - The board approved the share repurchase plan on January 24, 2024, allowing the use of self-owned funds for the repurchase [1] - The repurchase was executed within the stipulated timeframe, and the actual execution aligned with the disclosed plan [2] Share Structure Changes - The share structure before and after the cancellation is detailed, showing a reduction in unrestricted circulating shares from 1,207,429,528 to 1,189,203,552 [3] - The impact of the share cancellation on the company's financial status and operational results is deemed minimal, ensuring no harm to the interests of the company or minority investors [3]

证券代码：600718 证券简称：东软集团 公告编号：临 2025-050 一、回购实施情况 （一）回购审批情况 于 2024 年 1 月 24 日召开的公司十届六次董事会审议通过了《关于以集中竞 价交易方式回购公司股份的议案》。为维护公司价值和股东权益，董事会同意公 司使用自有资金以集中竞价交易方式回购公司股份，回购资金总额不低于人民币 1 亿元（含），不超过人民币 2 亿元（含），回购价格不超过人民币 12 元/股，回 购期限为自公司董事会审议通过回购股份方案之日起 3 个月内，回购所得股份将 在回购完成之后全部予以注销。具体内容，详见本公司于 2024 年 1 月 25 日刊登 在《中国证券报》《上海证券报》上的相关公告。 （二）回购实施情况 2024 年 4 月 24 日，公司完成回购，实际通过集中竞价方式回购公司股份 18,225,976 股，占公司当时总股本的 1.5020%，回购成交的最高价为 8.72 元/ 股，回购成交的最低价为 6.41 元/股，回购均价为 7.96 元/股，已支付资金总额 为 145,003,509.53 元人民币（不含印花税、佣金等交易费用），回购方案实际执 行情况与原 ...

Core Viewpoint - Neusoft Group received an inquiry letter from the Shanghai Stock Exchange regarding potential profit manipulation to meet specific performance targets after the release of its 2024 annual report [2][4] Financial Performance - Neusoft Group reported operating revenues of 10.544 billion yuan and 11.56 billion yuan for 2023 and 2024, respectively, with net profits attributable to shareholders of -147 million yuan and -36 million yuan during the same period, indicating a reduction in losses but still negative [6] - In 2024, the company achieved a net profit attributable to shareholders of 63 million yuan, a year-on-year decline of 14.7%, while the main business net profit was 435 million yuan, a year-on-year increase of approximately 22% [6] Stock Option Incentive Plan - The stock option incentive plan introduced in February 2024 set a unique performance assessment metric of "main business net profit," with a completion rate of 103.57% [4][6] - The company clarified that the main business net profit is defined as the net profit attributable to shareholders, excluding certain expenses and impacts from innovative business companies [6][7] Profit Adjustment Inquiry - The Shanghai Stock Exchange requested Neusoft to disclose the calculation process of the main business net profit, its audit status, and the reasons for the significant discrepancies between main business net profit and net profit attributable to shareholders [6][7] - Neusoft attributed the differences primarily to negative impacts from innovative business companies and the need to recognize impairment losses on long-term equity investments [7] High Borrowing Despite Cash Reserves - As of the end of the reporting period, Neusoft had cash reserves of 2.79 billion yuan, with short-term and long-term borrowings of 320 million yuan and 730 million yuan, respectively [9] - The company explained the high borrowing levels despite substantial cash reserves due to cash flow volatility, foreign exchange fluctuations, and the need to ensure operational safety [10]

Group 1 - Xikang was listed on the Hong Kong Stock Exchange on September 28, 2023, with a total shareholding of 23.66% by Neusoft Hong Kong after the global offering [1] - Neusoft Hong Kong purchased 6.9935 million shares of Xikang from November 2024 to January 2025, increasing its shareholding to 24.49% [1] - Neusoft Hong Kong has cumulatively invested 136 million yuan in Xikang since 2011, with a total recognized investment income of 910 million yuan due to equity method accounting [1] Group 2 - Wanghai was established in May 2003, with Neusoft holding a 32.37% stake, which does not constitute control [2] - Wanghai focuses on lean management, digital operations, and supply chain management for medical institutions, maintaining a leading position in hospital operation management systems [2] Group 3 - Neusoft acquired a 73.14% stake in Wanghai in 2011 for no more than 114.1 million yuan, aiming to enhance its core competitiveness [3] - In 2015-2016, Neusoft transferred 26.34% of its stake in Wanghai to introduce investors, raising 265.5 million yuan [6] - By December 2017, Neusoft's stake in Wanghai decreased to 34.8%, and it no longer consolidated Wanghai in its financial statements [10] Group 4 - Neusoft Ruichi was established in October 2015, with a registered capital of 1.566 billion yuan, and Neusoft holds a 29.82% stake [12] - Neusoft Ruichi focuses on automotive software, operating systems, and advanced driving assistance systems [12] - Neusoft has invested a total of 467 million yuan in Neusoft Ruichi from 2015 to 2018, with a recognized investment income of 929 million yuan [18] Group 5 - Rongsheng Insurance was established in July 2018 with a registered capital of 1.195 billion yuan, and Neusoft holds a 33.05% stake [19] - The company aims to innovate in property insurance with a focus on "Internet+" and has launched various insurance products since its establishment [19] - Neusoft invested a total of 395 million yuan in Rongsheng Insurance, with a recognized investment loss of 133 million yuan [22]

Core Viewpoint - The inquiry letter from the Shanghai Stock Exchange highlights discrepancies in Neusoft Group's financial performance, particularly in the healthcare and social security sectors, and requests detailed explanations regarding revenue recognition, profit adjustments, and customer relationships [2][3]. Financial Performance - Neusoft Group reported a net profit of 0.63 billion yuan for 2024, a year-on-year decline of 14.70%, while the net profit from core business increased by approximately 22% to 4.35 billion yuan [2]. - The average gross margin increased by 3.23 percentage points compared to 2022, indicating a growth trend [2]. Business Model and Operations - Neusoft operates in various sectors including healthcare, smart cities, and digital transformation, utilizing AI and data as core drivers for its solutions [4][6]. - The company provides integrated solutions in healthcare, including smart hospital services and medical insurance platforms, targeting both large and small medical institutions [4][5][6]. Revenue Recognition and Client Relationships - The company employs a phased payment model for its services, with revenue recognized based on contract terms and project milestones [7][14]. - Neusoft's major clients include various government and healthcare entities, with detailed disclosures required regarding the top ten clients and their associated transactions [18][19]. Industry Comparisons - The inquiry letter requests explanations for discrepancies in revenue and gross margin trends compared to peer companies in the healthcare and social security sectors [3][4]. - Neusoft's business model remains consistent across its various sectors, with revenue recognition policies aligned with industry standards [11][16].

立信会计师事务所（特殊普通合伙） 关于东软集团股份有限公司 2024 年年度报告的信息披露监管问询函的回复 信会师函字[2025]第 ZA236 号 上海证券交易所： 贵所出具的《关于东软集团股份有限公司 2024 年年度报告的信息披露监管问询函》"上 证公函【2025】0645 号"（以下简称"问询函"）已收悉。立信会计师事务所（特殊普通合伙） （以下简称"立信会计师"）作为公司年审会计师，对工作函提到的需要立信会计师说明或发 表意见的问题进行了审慎核查，现将核查情况和核查意见做如下说明： 问题 1 1.年报及前期公告显示，公司 2023 年至 2024 年分别实现营业收入 105.44 亿元、115.60 亿元，平均毛利率较 2022 年增加 3.23 个百分点，均呈增长趋势；同期扣非后归母净利润分 别为-1.47 亿元、-0.36 亿元，减亏但仍为亏损。分行业看，部分业务尤其是医疗健康及社会 保障、智慧城市业务近两年营业收入、毛利率变动趋势与公司前期披露的可比公司同类业 务存在差异。此外，公司 2024 年实现归母净利润 0.63 亿元，同比下滑 14.70%，实现主营 业务净利润 4.35 亿元，同比 ...

银信资产评估有限公司对关于东软集团股份有限公 司 2024 年年度报告的信息披露监管问询函的回复 上海证券交易所: 银信资产评估有限公司接受委托,担任东软集团股份有限公司以 财务报告为目的的减值事宜涉及的东软睿驰汽车技术(上海)有限公 司的评估机构,现就贵所出具的《关于东软集团股份有限公司 2024 年年度报告的信息披露监管问询函》(上证公函【2025】0645 号）提 及的需评估机构回复的相关事项进行了回复,发表回复意见如下: 2. 年报及前期公告显示,报告期末公司长期股权投资余额 35.82 亿元,主要为对联营企业的投资,报告期内在权益法下确认投资损失 1.78亿元,其中对东软医疗系统股份有限公司(以下简称东软医疗)、 东软睿驰汽车技术(上海)有限公司(以下简称东软睿驰)、熙康云 医院控股有限公司(以下简称熙康云医院)、望海康信(北京)科技 股份公司（以下简称望海康信）、融盛财产保险股份有限公司（以下 简称融盛保险)等 5 家联营企业分别确认投资损失 0.79 亿元、0.45 亿元、0.20 亿元、0.16 亿元、0.17 亿元,金额较大。其中,东软医 疗报告期内由盈转亏,东软睿驰、融盛保险最近3年均亏损 ...

上海东洲资产评估有限公司对关于东软集团股份有 限公司 2024年年度报告的信息披露监管问询函的回 复 上海证券交易所: 上海东洲资产评估有限公司接受委托,担任东软集团股份有限 公司以财务报告为目的的减值事宜涉及的熙康云医院控股有限公 司、望海康信(北京)科技股份公司的评估机构,现就贵所出具的 《关于东软集团股份有限公司 2024 年年度报告的信息披露监管问询 函》(上证公函《2025》0645 号）提及的需评估机构回复的相关事 项进行了回复,发表回复意见如下: 2. 年报及前期公告显示,报告期末公司长期股权投资余额35. 82 亿元,主要为对联营企业的投资,报告期内在权益法下确认投资 损失1.78亿元,其中对东软医疗系统股份有限公司(以下简称东软医疗 ）、东软睿驰汽车技术(上海)有限公司(以下简称东软睿驰)、熙康 云医院控股有限公司(以下简称熙康云医院)、望海康信(北京)科技股份 公司（以下简称望海康信）、融盛财产保险股份有限公司（以下简称融盛保险 ）等5家联营企业分别确认投资损失0.79亿元、0.45亿元、0.20亿元、 0.16亿元、0.17亿元,金额较大。其中,东软医疗报告期内由盈转亏 ，东软睿驰、融盛 ...